Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
November 09 2017 - 6:00AM
Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics
company, today announced that the Company's Chairman and Chief
Executive Officer, Paul Cowan, will present at the Jefferies 2017
London Healthcare Conference on Thursday, November 16, 2017 at 9:20
a.m. GMT (4:20 a.m. Eastern Time) at the Waldorf Hilton in London,
U.K. The Company's Chief Financial Officer, Chris Lindop, will also
be participating in the conference.
A webcast of the presentation will be available online from the
investor relations page of the Company's corporate website
at www.quotientbd.com. A webcast replay will be archived on
the website for approximately 90 days.
About Quotient Limited
Quotient is a commercial-stage diagnostics company committed to
reducing healthcare costs and improving patient care through the
provision of innovative tests within established markets. With an
initial focus on blood grouping and serological disease screening,
Quotient is developing its proprietary MosaiQ™ technology platform
to offer a breadth of tests that is unmatched by existing
commercially available transfusion diagnostic instrument platforms.
The company's operations are based in Edinburgh, Scotland; Eysins,
Switzerland and Newtown, Pennsylvania.
The Quotient logo and MosaiQ™ are registered trademarks or
trademarks of Quotient Limited and its subsidiaries in various
jurisdictions.
CONTACT: Chris Lindop, Chief Financial Officer
—chris.lindop@Quotientbd.com; +41 (0)799 61 69 38
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quotient (NASDAQ:QTNT)
Historical Stock Chart
From Apr 2023 to Apr 2024